Merger Notification - Announcement according to § 10 Cartel Act
Stryker Corporation; Cerus Endovascular Limited
BWB/Z-6133
On 24.11.2022 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Acquisition of 100 % of the shares in and sole control over Cerus Endovascular Limited (UK) by Stryker Corporation (USA).
Economic Sector: Manufacture of medical and dental instruments and supplies; Wholesale of pharmaceutical goods
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren F - Baugewerbe/Bau
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 22.12.2022.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 23.12.2022 .